“Comparative Efficacy and Safety of Daily Versus Alternate Day Dosing of Rosuvastatin in Dyslipidemic Patients: A Prospective, Randomized, Open Label Study”. International Journal of Public Research in Medicine and Health, vol. 1, no. 1, Sept. 2025, pp. 10-19, https://doi.org/10.66328/ijprmh.2025.010103.